Y-Intercept (HK)’s Aura Biosciences AURA Stock Holding History

Y-Intercept (HK)’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.09M	Buy	+174,121	New	+$1.24M	0.02%	968

Other funds holding AURA

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Y-Intercept (HK)'s AURA Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Aura Biosciences (AURA) in Q3 2026: 174,121 shares worth $1.09M. The stake represents 0.02% of the portfolio and ranks #968 among its holdings.

27 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

Y-Intercept (HK) held 174,121 shares of Aura Biosciences worth $1.09M as of Q3 2026.
Aura Biosciences was a new Y-Intercept (HK) position in Q3 2026.
Aura Biosciences made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #968 holding.
27 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.